Imunon, Inc. Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
Imunon, Inc. (IMNN) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of $8.65 thousand for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2014-08-07
- Imunon, Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2014-06-30 was $12.99K.
- Imunon, Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2014-03-31 was -$4.34K.
- Imunon, Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2013-09-30 was -$200.71K.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month |
|---|---|---|---|
| 2014-06-30 | $12.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $8.65K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$4.34K 10-Q · filed 2014-05-08 | ||
| 2013-09-30 | -$200.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$478.63K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$277.92K 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |